EU closing in on COVID-19 vaccine deals with J&J, GSK- Sanofi as COVAX works toward equitable access

The European Commission is close to securing access to two COVID-19 vaccines for its member states. On Thursday, the EU reached a preliminary agreement with J&J for 200 million doses of its adenovirus vector vaccine, after nearing a deal last month with GSK and Sanofi for 300 million doses. 

The deal talks come as an international consortium works to secure global access to COVID-19 vaccines...